StemCells Therapy

23-03-2012 13:00 Regenerative Medicine is a revolutionary medical approach that taps into the body’s innate ability to regenerate or heal itself. Organogenesis specializes in bringing this exciting new approach to patients today.

Weve heard of people freezing their eggs, blood and stem cells for use later on, but a health service startup is now enabling patients to freeze their own skin cells for potential future use in diagnostics, therapeutics and regenerative medicine techniques.

ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc.

Four-year-old Angela Irizarry was born with a single pumping chamber in her heart, a potentially lethal defect. To fix the problem, Angela is growing a new blood vessel in her body in an experimental treatment that could advance the burgeoning field of regenerative medicine.

Newswise MANHATTAN, KAN. — Research from a Kansas State University professor may make it easier to recover after spinal cord injury or to study neurological disorders. Mark Weiss, professor of anatomy and physiology, is researching genetic models for spinal cord injury or diseases such as Parkinson’s disease

CLEARWATER, FL–(Marketwire -03/19/12)- Biostem U.S., Corporation (OTCQB: BOSM.PK – News) (Pinksheets: BOSM.PK – News) (Biostem, the Company), a fully reporting public company in the stem cell regenerative medicine sciences sector, announced today the addition of Perinatologist Sanford M. Lederman, MD to its Scientific and Medical Board of Advisors (SAMBA). As Chairman of the Department of Obstetrics and Gynecology at New York Methodist Hospital in Brooklyn, Dr.

WINSTON-SALEM, N.C., March 19, 2012 /PRNewswire/ — Tengion, Inc. (NASDAQ: TNGN – News), a leader in regenerative medicine, today announced it will host a conference call and live audio webcast on Monday, March 26, 2012, at 5:00 p.m. EDT to provide a business update and discuss its fourth quarter 2011 financial results

28-12-2011 05:37 Ceraxon Citicoline – link to online store GenuineTabs.com Modafinil (Modalert) 100 mg / 200 mg Modalert (modafinil) is a medication that promotes wakefulness. It is thought to work by altering the natural chemicals (neurotransmitters) in the brain. The best quality of smart drugs ceraxon…

16-03-2012 11:56 Craig Venter, president and founder of the J. Craig Venter Institute, spoke to the California Institute for Regenerative Medicine governing board on January 17th, 2012, about the future of personalized medicine in which genomics, the study of genes and their function, is applied to pinpoint specific treatments for patients.

13-03-2012 21:42 Dr Oz on the latest regenerative medicine

SUNRISE, Fla., March 15, 2012 (GLOBE NEWSWIRE) — Bioheart, Inc.

13-03-2012 16:42 Hear Dr. Bowen talk about the exciting field of Regenerative Medicine. The type of regenerative medicine Dr.

ALAMEDA, Calif.–(BUSINESS WIRE)– BioTime, Inc.

MARLBOROUGH, Mass.–(BUSINESS WIRE)– Advanced Cell Technology, Inc.

08-03-2012 13:51 Brief introduction to our services, staff and facilities.

08-03-2012 10:30

MARLBOROUGH, Mass.–(BUSINESS WIRE)– Advanced Cell Technology, Inc. (ACT; OTCBB: ACTC), a leader in the field of regenerative medicine, announced today that the companys chairman and CEO, Gary Rabin, will be presenting at Roth Capital Partners 24th Annual ROTH Conference, March 11-14

Organogenesis Inc. of Canton, a leader in the regenerative medicine field, announced today its product, Gintuit, which is designed to form new gum tissue for dental patients, has been approved by the U.S.

Today Organogenesis Inc., a business leader in the regenerative medicine field, announced that the United States Food and Drug Administration (FDA) has approved GINTUIT (Allogeneic Cultured Keratinocytes and Fibroblasts in Bovine Collagen), a cell-based product that has been shown to predictably generate new and aesthetically appealing oral soft tissue (gum tissue). The GINTUIT approval marks two important firsts: the first-ever approval of an allogeneic cell product via the Center for Biologics Evaluation and Research (CBER) arm of the FDA, and the first cell-based technology that is FDA-approved for use in the dental market

Robert Shaw, left, commercial director of EMD Millipores Stem Cell Initiative, and Michael May, CEO of the Centre for Commercialization of Regenerative Medicine in Toronto. EMD Millipore, the Billerica-based life science division of Merck KGaA, said today that it is collaborating with the Centre for Commercialization of Regenerative Medicine in Toronto to develop optimized conditions to cultivate stem cells in a bioreactor.